Actualités id6251.html
In development: Guidance, quality standards and advice
Sun, 09 Feb 2025 08:38:00 GMT
Palbociclib with trastuzumab and endocrine therapy for maintenance treatment of hormone-receptor positive, HER2-positive metastatic breast cancer [ID6251] Technology appraisal guidance TBC ...